» Articles » PMID: 1672520

Comparison of the Membrane Transport of Anthracycline Derivatives in Drug-resistant and Drug-sensitive K562 Cells

Overview
Journal Eur J Biochem
Specialty Biochemistry
Date 1991 Mar 14
PMID 1672520
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

One of the phenotypes of multidrug resistance is characterized by a decrease in the intracellular concentration of drug in resistant cells as compared to sensitive cells. This is correlated with the presence in the membrane of resistant cells of a 150-180-kDa glycoprotein, P-glycoprotein, responsible for an active efflux of the drug. The fluorescence emission spectra from anthracycline-treated cells suspended in buffer have been used to compare the membrane transport of five anthracycline derivatives: adriamycin, daunorubucin, 4'-o-tetrahydropyranyladriamycin, carminomycin and aclacinomycin in drug-sensitive and drug-resistant K562 cells. The initial rate of uptake of these five drugs has been measured as a function of the extracellular pH, pHe. The data show that the uptake occurs through free permeation of the neutral form of the drug. For each drug an influx coefficient kpHe, characteristic of the drug and of the cell type has been defined and calculated: k+(7.2) = V+/[D]e.n where V+ and [D]e are the initial rate of uptake and the concentration of drug in the medium at pHe = 7.2 respectively and n is the number of cells. This coefficient is characteristic of a passive diffusion of the neutral form of the drug through the lipid bilayer. Efflux coefficients k-(7.2)- at pHi = 7.2 (the intracellular pH value) have also been calculated. In the case of sensitive cells, k+(7.2) and k-(7.2)- are equal. For resistant cells, the efflux coefficient is composed of two terms: (a) (k-)p corresponding to the passive diffusion of the neutral form of the drug and (k-)p = k+; (b) (k-)a corresponding to an active efflux mediated by the P-glycoprotein. Our data suggest that the anthracycline derivatives efflux actively in the neutral form.

Citing Articles

Modulation of p-glycoprotein-mediated efflux pirarubicin in living multidrug-resistant K562/Dox cell lines by 4-hydroxybenzoic acid and 4-hydroxy-3-methoxybenzoic acid via impairment of the cellular energetic state.

Myint O, Wattanapongpitak S, Kothan S, Udomtanakunchai C, Tima S, Tungjai M Toxicol Rep. 2022; 9:1443-1451.

PMID: 36518452 PMC: 9742882. DOI: 10.1016/j.toxrep.2022.06.017.


Real-time imaging and quantitative analysis of doxorubicin transport in a perfusable microvessel platform.

Bogorad M, Searson P Integr Biol (Camb). 2016; 8(9):976-84.

PMID: 27523481 PMC: 5035133. DOI: 10.1039/c6ib00082g.


Decrease of P-glycoprotein activity in K562/ADR cells by MbetaCD and filipin and lack of effect induced by cholesterol oxidase indicate that this transporter is not located in rafts.

Reungpatthanaphong P, Marbeuf-Gueye C, Le Moyec L, Salerno M, Garnier-Suillerot A J Bioenerg Biomembr. 2005; 36(6):533-43.

PMID: 15692732 DOI: 10.1007/s10863-004-9000-8.


Anthrapyridones, a novel group of antitumour non-cross resistant anthraquinone analogues. Synthesis and molecular basis of the cytotoxic activity towards K562/DOX cells.

Tarasiuk J, Stefanska B, Plodzich I, Seksek O, Martelli S, Garnier-Suillerot A Br J Pharmacol. 2002; 135(6):1513-23.

PMID: 11906965 PMC: 1573273. DOI: 10.1038/sj.bjp.0704611.


Efficiency of doxorubicin handling by isolated hepatocytes is a valuable indicator for restored cell function.

Crivellato E, Donini A, Baccarani U, Lavaroni S, Candussio L, Degrassi A Histochem J. 2000; 32(9):535-43.

PMID: 11127974 DOI: 10.1023/a:1004198127027.